30
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy

, , , , &
Pages 1117-1123 | Received 13 Mar 1996, Accepted 12 Jul 1996, Published online: 02 Jul 2009

References

  • Fiedler F. Enzymology of glandular kallikrein. Handbook of Experimental Pharmacology, E. G. Erdos. Springer-Verlag, New York 1979; 25: 103–161
  • Bhoola K. D., Figueroa C. D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and ki-ninases. Pharmacol. Rev. 1992; 44: 1–80
  • Cuthbert A. W., Margolius H. S. Kinins stimulate net chloride secretion by the rat colon. Br. J. Pharmacol. 1982; 75: 578–598
  • Carretero O. A., Scicli A. G. The renal kallikrein-kinin system in human and experimental essential hypertension. Endocrine Mechanisms in Hypertension, J. H. Laragh, B. M. Brenner, N. M. Kaplan. Raven Press Publishers, New York 1989; 219–239
  • Schachter M. Kallikreins (kininogenases)-a group of serine proteases with bioregulatory actions. Pharmacol. Rev. 1980; 31: 1–17
  • Margolius H. S. Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases. Ann. Rev. Pharmacol. Toxicol. 1989; 29: 343–364
  • Murray S. R., Chao J., Lin F.-K., Chao L. Kallikrein multigene families and the regulation of their expression. J. Card. Pharmacol. 1990; 15(Suppl. 6)S7–S16
  • Xiong W., Tang C. Q., Zhou G. X., Chao L., Chao J. In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein. J. Lab. Clin. Med. 1992; 119: 514–521
  • Zhou G., Chao L., Chao J. Kallistatin: a novel human tissue kallikrein inhibitor. J. Biol. Chem. 1992; 267: 25873–25880
  • Chao J., Tillman D. J., Wang M., Margolius H. S., Chao L. Identification of a new tissue-kallikrein-binding protein. Biochem. J. 1986; 239: 325–331
  • Chao J., Chai K.-X., Chen L.-M., Xiong W., Chao S., Woodley-Miller C., Wang L., Lu H. S., Chao L. Tissue kallikrein-binding protein is a serpin. J. Biol. Chem. 1989; 265: 16394–16401
  • Serveau C., Moreau T., Zhou G. X., Chao J., Gauthier F. Inhibition of rat tissue kallikrein gene family members by rats kallikrein-binding protein and alpha 1-proteinase inhibitor. FEBS Lett. 1992; 309: 405–408
  • Chao J., Chao L. A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats. J. Hypertension 1988; 6: 551–557
  • Chai K. X., Ward D. C., Chao J., Chao L. Molecular cloning, sequence analysis, and chromosomal localization of human kallistatin gene. Genomics 1994; 23: 370–378
  • Lindpaintner K., Chai K. X., Kreutz R., Hubner N., Ganten D., Chao L., Chao J. Linkage of the kallikrein-binding protein gene locus to sodium sensitivity: effects on blood pressure regulation and chromosomal localization. J. Clin. Invest. 1996, In Press
  • Ma J.-X., Yang Z., Chao J., Chao L. Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. J. Biol. Chem. 1995; 270: 451–455
  • Jaffa A. A., Miller D. H., Bailey G. S., Chao J., Margolius H. S., Mayfield R. K. Abnormal regulation of renal kallikrein in experimental diabetes; effects of insulin on prokallikrein synthesis and activation. J. Clin. Invest. 1987; 80: 1651–1659
  • Yasujima M., Yoshida K., Kanazawa M., Kohzuki M., Omata K., Watanabe H., Hiwatari M., Sato T., Abe K. Urinary active kallikrein excretion and diabetic renal impairments in streptozotocin-treated rats. Tohoku J. Exp. Med. 1993; 171: 135–144
  • Mayfield R. K., Margolius H. S., Levine J. H., Wohlt-mann H. J., Loadholt C. B., Colwell H. A. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. J. Clin. Endocrinol. Metab. 1984; 59: 278–286
  • Mombouli J. V., Vanhoutte P. M. Kinins and endothelial control of vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 1995; 35: 679–705
  • Ma J.-X., Song Q., Crouch R. K., Chao J. Localization of tissue kallikrein, low molecular weight kininogen and bradykinin B2 receptor in human retina and choroid. Exp. Eye Res. 1996, In Press
  • Ma J.-X., Bensaoula T., Hatcher H. C., Ottlecz A. Kallistatin is decreased in the retina of diabetic rats. (Abstract). Invest. Ophthal. Vis. Sci. 1996, In Press
  • Chen L.-M., Song Q., Chao L., Chao J. Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney. Kidney International 1995; 48: 690–697
  • Steele F. R., Chader G. J., Johnson L. V., Tombran-Tink J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl. Acad. Sci. USA 1993; 90: 1526–1530
  • Bao J.-J., Sifers R. N., Kidd V. J., Ledley F. D., Woo S. L. Molecular evolution of serpins: homologous structure of the human α 1 antichymotrypsin and α 1-anti-trypsin genes. Biochemistry 1987; 26: 7755–7759
  • Twining S. S., Fukuchi T., Yue B. Y. J.T., Wilson P. M., Boskovic G. Corneal synthesis of α 1-proteinase inhibitor (α 1-antitrypsin). Invest. Ophthal. Vis. Sci. 1994; 35: 458–462
  • Twining S. S., Fukuchi T., Yue B. Y. J.T., Wilson P. M., Zhou X. α 1-antichymotrypsin is present in and synthesized by the cornea. Curr. Eye Res. 1994; 13: 433–439
  • Schunkert H., Ingelfinger J. R., Jacob H., Jackson B., Bouyounes B., Dzau V. J. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am. J. Physiol. 1992; 263(5Pt 1)E863–869
  • Gasc J. M., Monnot C., Clauser E., Corvol P. Co-expression of type 1 angiotensin II receptor (ATIR) and renin mRNA in juxtaglomerular cells of the rat kidney. Endocrinology 1993; 132: 2723–2725
  • Yoon J.-B., Towle H. C., Seelig S. Growth hormone induces two mRNA species of the serine protease inhibitor gene family in rat liver. J. Biol. Chem. 1987; 262: 4284–4289
  • Manner R. M., Donaldson M. L., Low C., Fenton P. J. Corneal ulceration in a patient with α 1-antitrypsin deficiency. Br. J. Ophthalmol. 1994; 78: 653–654
  • Akaaboune M., Ma J.-X., Festoff B. W., Greenberg B. D., Hantai D. Neurotrophic regulation of mouse muscle β-amyloid protein precursor and α 1-antichymotryp-sin as revealed by axotomy. J. Neurobiol. 1994; 25: 503–514
  • Chai K. X., Ma J.-X., Murray S. R., Chao J., Chao L. Molecular cloning and analysis of the rat kallikrein-binding protein gene. J. Biol. Chem. 1991; 266: 16029–16036
  • Chao J., Chao L. Biochemistry, regulation and potential function of kallistatin. Biol. Chem. Hoppe-Seyler 1995; 376: 705–713
  • Berry S. A., Seelig S. Substantial induction of a new serum protein by growth hormone: physiochemical and physiological characterization. Endocrinology 1984; 115: 1164–1170
  • Le Cam A., Pages G., Auberger P., Le Cam G., Leopold P., Benarous R., Glaichenhaus N. Study of a growth hormone-regulated protein secreted by rat hepato-cytes: cDNA cloning, anti-protease activity and regulation of its synthesis by various hormones. EMBOJ. 1987; 6: 1225–1232
  • Ma J.-X., Chao J., Chao L. Rat kallikrein-binding protein gene contains two promoters. Biochi. Biophys. Acta 1996, In Press
  • Garner A. Histopathology of diabetic retinopathy in man. Eye 1993; 7: 250–253
  • Kohner E. M., Patel V., Rassam S. M. B. Role of blood flow and impaired autoregulation in the patho-genesis of diabetic retinopathy. Diabetes 1995; 44: 603–607

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.